We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Medical News and Perspectives |

New Guidance for ICD Implantation Offers Decision Aids for Physicians and Patients

Mike Mitka, MSJ
JAMA. 2013;309(16):1671-1672. doi:10.1001/jama.2013.3541.
Text Size: A A A
Published online


Key cardiology groups have issued guidance for the appropriate use of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy. The February publication follows a federal investigation into ICD implantation and a study suggesting that more than 1 in 5 ICDs is implanted inappropriately.

The guidance establishes criteria that cover 6 areas: ICDs for primary prevention, ICDs for secondary prevention, comorbidities, cardiac resynchronization therapy devices, generator replacements with preexisting cardiovascular implantable electronic devices, and dual- vs single-chamber ICDs (http://tinyurl.com/cstq7p8). The document was developed by the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS) along with key specialty societies, including the American Heart Association (AHA). It is to be used in conjunction with the “ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities” and its 2012 focused update.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

A 2011 study found a high rate of inappropriate use of implantable cardioverter-defibrillators, such as in patients with chronic heart failure of less than 3 months duration or in patients within 40 days of acute myocardial infarction or within 90 days of coronary artery bypass graft surgery.



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles